![Mark A. Wyatt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark A. Wyatt
Directeur/Membre du Conseil chez
Femeda Ltd.
Profil
Mark A. Wyatt currently works at Femeda Ltd., as Director and Northern Gritstone Ltd, as Investment Manager.
Dr. Wyatt also formerly worked at TheraCryf Plc, as Non-Executive Director, Mercia Regional Ventures Ltd., as Director-Investment from 2003 to 2008, Mercia Regional Ventures Ltd., as Investment Director from 2010 to 2016, Mercia Fund Management Ltd., as Investment Director, Cizzle Biotechnology Ltd., as Director, Evgen Ltd., as Non-Executive Director, Enterprise Ventures Group Ltd., as Investment Director, Optibiotix Health Plc, as Non-Executive Director from 2014 to 2016, Mercia Asset Management Plc, as Investment Director, MyHealthChecked Plc, as Independent Non-Executive Director from 2016 to 2018, Excalibur Fund Managers Ltd., as Associate, IP2IPO Innovations Ltd., as Manager-Bioscience Ventures, and Touchstone Innovations Investment Management Ltd., as Bioscience Ventures Manager in 2010.
Dr. Wyatt received his undergraduate degree from the University of Bath, doctorate degree from the University of Cambridge, and Masters Business Admin degree from the University of Warwick.
Postes actifs de Mark A. Wyatt
| Sociétés | Poste | Début |
|---|---|---|
Femeda Ltd.
 Femeda Ltd. Medical SpecialtiesHealth Technology Manufacture of irradiation, electromedical and electrotherapeutic equipment | Directeur/Membre du Conseil | - |
Northern Gritstone Ltd.
 Northern Gritstone Ltd. Investment ManagersFinance Northern Gritstone invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions. | Private Equity Investor | - |
Anciens postes connus de Mark A. Wyatt
| Sociétés | Poste | Fin |
|---|---|---|
| FORTIS FRONTIER PLC | Directeur/Membre du Conseil | 17/07/2018 |
Cizzle Biotechnology Ltd.
 Cizzle Biotechnology Ltd. BiotechnologyHealth Technology Develops therapeutic products for lung cancer | Directeur/Membre du Conseil | 25/04/2017 |
| THERACRYF PLC | Directeur/Membre du Conseil | 03/04/2017 |
Enterprise Ventures Ltd.
 Enterprise Ventures Ltd. Investment ManagersFinance Enterprise Ventures invests invests in small and medium sized enterprises companies located in the UK. The firm targets companies operating in wide range of sectors. The firm provides financing in the form of debt and private equity for buyout and early stage capital requirements. | Private Equity Investor | 10/03/2016 |
| OPTIBIOTIX HEALTH PLC | Directeur/Membre du Conseil | 01/01/2016 |
Formation de Mark A. Wyatt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Evgen Pharma Plc
 Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
University of Bath
 University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enterprise Ventures Ltd.
Enterprise Ventures Ltd. Investment ManagersFinance Enterprise Ventures invests invests in small and medium sized enterprises companies located in the UK. The firm targets companies operating in wide range of sectors. The firm provides financing in the form of debt and private equity for buyout and early stage capital requirements. | Finance |
Excalibur Fund Managers Ltd.
 Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur invests in companies located in the United Kingdom. The firm targets companies operating in the fields of biotechnology and medical devices. It provide financing for mezzanine, seed, early and later stage capital requirements. | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IP2IPO Innovations Ltd.
 IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business development and technology transfer services | Commercial Services |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Touchstone Innovations Investment Management Ltd.
 Touchstone Innovations Investment Management Ltd. Investment ManagersFinance IIIM is an active manager which invests in technology businesses based on intellectual property from Imperial College. The company also invests in companies that have been through the incubation process managed by the Imperial Innovations' New Ventures team. The firm leads or co-leads investment rounds in technology companies across all stages of development in the healthcare, energy, environment and emerging technology sectors. Companies seeking first round funding and beyond are expected to have demonstrated that they have recruited of an experienced CEO and CTO, have a functioning board including an experienced Chairman and at least one non-executive director appointed by IIIM, have financial controls and responsible financial management, have resolved initial intellectual property technical risk, have a clear, credible and commercial business plan and have identified a location for the company to achieve full independence IIIM works toward exits through trade sales, mergers or IPOs. | Finance |
Mercia Fund Management Ltd.
 Mercia Fund Management Ltd. Investment ManagersFinance Mercia Fund invests in companies located in the United Kingdom. The firm targets companies operating in a broad range of sectors. It provides financing for seed, early and growth stage capital requirements. The firm also participates in MBOs, buy-in, acquisition financing, debt, and mezzanine transactions with an investment size of GBP 1 - 10 million. It also acquires minority investments. | Finance |
Femeda Ltd.
Femeda Ltd. Medical SpecialtiesHealth Technology Manufacture of irradiation, electromedical and electrotherapeutic equipment | Health Technology |
Cizzle Biotechnology Ltd.
Cizzle Biotechnology Ltd. BiotechnologyHealth Technology Develops therapeutic products for lung cancer | Health Technology |
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Develops novel glucosinolate based products for the prevention and treatment of human disease | Health Services |
Enterprise Ventures Group Ltd.
 Enterprise Ventures Group Ltd. Investment ManagersFinance Provides venture capital and loans to small businesses | Finance |
Optibiotix Health Plc
 Optibiotix Health Plc BiotechnologyHealth Technology Develops biological products for digestive health | Health Technology |
Mercia Asset Management Plc
 Mercia Asset Management Plc Financial ConglomeratesFinance Provides private equity and venture capital fund management services | Finance |
MyHealthChecked Plc
 MyHealthChecked Plc Medical SpecialtiesHealth Technology Develops products for the female health diagnostics sector including software apps | Health Technology |
Northern Gritstone Ltd.
Northern Gritstone Ltd. Investment ManagersFinance Northern Gritstone invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions. | Finance |
